Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35556360)
Watch
English
The biology of TNF blockade
scientific article published on October 1, 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
The biology of TNF blockade
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
main subject
intracellular signaling peptides and proteins
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550876
retrieved
20 March 2024
immunology
1 reference
stated in
Crossref
DOI
10.1016/S1568-9972(03)00048-X
reference URL
https://api.crossref.org/works/10.1016/S1568-9972(03)00048-X
retrieved
20 March 2024
author name string
Arun G. Suryaprasad
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550876
retrieved
20 March 2024
T. Prindiville
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550876
retrieved
20 March 2024
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
1 October 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
full work available at URL
https://api.elsevier.com/content/article/PII:S156899720300048X?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1016/S1568-9972(03)00048-X
reference URL
https://api.crossref.org/works/10.1016/S1568-9972(03)00048-X
retrieved
20 March 2024
https://api.elsevier.com/content/article/PII:S156899720300048X?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1016/S1568-9972(03)00048-X
reference URL
https://api.crossref.org/works/10.1016/S1568-9972(03)00048-X
retrieved
20 March 2024
published in
Autoimmunity Reviews
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
volume
2
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
issue
6
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
page(s)
346-357
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
cites work
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for the treatment of fistulas in patients with Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arguments for interleukin 1 as a target in chronic arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-cytokine therapy in chronic destructive arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ethnic-specific genetic associations with pulmonary tuberculosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of response to infliximab in patients with Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900048-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes
series ordinal
30
1 reference
stated in
Crossref
DOI
10.1016/S1568-9972(03)00048-X
reference URL
https://api.crossref.org/works/10.1016/S1568-9972(03)00048-X
retrieved
20 March 2024
Identifiers
DOI
10.1016/S1568-9972(03)00048-X
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
PubMed ID
14550876
1 reference
stated in
Europe PubMed Central
PubMed ID
14550876
retrieved
8 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
